Ticker

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker  Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Picard between September 2, 2025, and October 31, 2025 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com…

- Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first and only total artificial heart approved by both the U.S. FDA and Health Canada,…

/C O R R E C T I O N -- Fundstrat Capital/ PR Newswire NEW YORK, June 9, 2026 In the

/C O R R E C T I O N -- Fundstrat Capital/ PR Newswire NEW YORK, June 3, 2026 In the

–First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform– –First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform–